Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Accured Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Precigen (PGEN) Notes Payables (2022 - 2023)

Precigen (PGEN) has disclosed Notes Payables for 2 consecutive years, with $13.8 million as the latest value for Q1 2023.

Quarterly Notes Payables changed N/A to $13.8 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $13.8 million through Mar 2023, changed N/A year-over-year, with the annual reading at $43.2 million for FY2022, N/A changed from the prior year.
Notes Payables for Q1 2023 was $13.8 million at Precigen, down from $43.2 million in the prior quarter.
The five-year high for Notes Payables was $43.2 million in Q4 2022, with the low at $13.8 million in Q1 2023.